David Eigen

David Eigen possesses a strong background in finance and law, having earned a Bachelor of Science in Finance from The Wharton School and a Juris Doctor from the Cardozo School of Law. Currently, David serves as a Board Member at LyfeMD and a Board Observer at both binah.ai and Clarapath, Inc. Additionally, David holds the position of Chief Executive Officer at LEVIANT and acts as Managing Member at P5 Health Ventures.